首页> 美国卫生研究院文献>Clinical Ophthalmology (Auckland N.Z.) >Efficacy and safety of two new formulations of artificial tears in subjects with dry eye disease: a 3-month multicenter active-controlled randomized trial

【2h】

Efficacy and safety of two new formulations of artificial tears in subjects with dry eye disease: a 3-month multicenter active-controlled randomized trial

机译：两种新配方的人工泪液在干眼症患者中的功效和安全性：一项为期3个月的多中心主动对照随机试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

PurposeTo evaluate and compare the efficacy and safety of two investigational artificial tear formulations (CHO-1 and CHO-2) containing carmellose sodium, hyaluronic acid at different concentrations, and osmoprotectants, with a standard carmellose sodium-containing formulation (Refresh Tears [RT]) in the treatment of dry eye disease.

机译：目的使用标准的含羧甲基纤维素钠的制剂（刷新眼泪[RT]）评估和比较两种研究性人工泪液制剂（CHO-1和CHO-2）的功效和安全性，这些制剂包含羧甲基纤维素钠，不同浓度的透明质酸和渗透保护剂。）治疗干眼症。

著录项

期刊名称 Clinical Ophthalmology (Auckland N.Z.)
作者
Peter A Simmons; Haixia Liu; Cindy Carlisle-Wilcox; Joseph G Vehige;
展开▼
作者单位

展开▼
年(卷),期 2015(9),-1
年度 2015
页码 665–675
总页数 11
原文格式 PDF
正文语种
中图分类眼科学;
关键词
dry eye syndromes ophthalmic solutions carmellose hyaluronic acid;

机译：干眼症候群;眼药水;羧甲基纤维素;透明质酸;

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of two new formulations of artificial tears in subjects with dry eye disease: a 3-month, multicenter, active-controlled, randomized trial [J] . Peter A Simmons, Haixia Liu, Cindy Carlisle-Wilcox, Clinical ophthalmology . 2015,第4期

机译：两种新配方的人工泪液在干眼症患者中的功效和安全性：一项为期3个月的多中心主动对照随机试验
2. Efficacy, Safety, and Acceptability of a Lipid-Based Artificial Tear Formulation: A Randomized, Controlled, Multicenter Clinical Trial [J] . Simmons Peter A., Carlisle-Wilcox Cindy, Chen Ru, Clinical therapeutics . 2015,第4期

机译：基于脂质的人工泪液制剂的功效，安全性和可接受性：随机，对照，多中心临床试验
3. Tear volume estimation using a modified Schirmer test: a randomized, multicenter, double-blind trial comparing 3% diquafosol ophthalmic solution and artificial tears in dry eye patients [J] . Hideki Miyake, Yuri Kawano, Hiroshi Tanaka, Clinical ophthalmology . 2016,第3期

机译：使用改良的Schirmer检验估算泪液量：一项随机，多中心，双盲试验，比较了干眼症患者中3％的Diquafosol眼药水和人工泪液
4. Assessment of the efficacy of topical cyclosporine for Dry Eye Disease induced by mustard gas using tear osmolarity measurement [C] . Jadidi K., Ebrahimi A., Rezaee M., International Symposium on Ocular Pharmacology and Therapeutics . 2013

机译：用泪液测量评估芥子气体诱导的芥子气体诱导的干眼症疗效的疗效
5. Efficacy and safety of novel collagen conduits filled with collagen filaments to treat patients with peripheral nerve injury: A multicenter, controlled, open-label clinical trial [D] . Saeki Masaomi, 佐伯将臣 2019

机译：充满胶原细丝的新型胶原蛋白导管治疗周围神经损伤患者的疗效和安全性：一项多中心，对照，开放标签的临床试验
6. Safety and Efficacy of a Preservative-Free Artificial Tear Containing Carboxymethylcellulose and Hyaluronic Acid for Dry Eye Disease: A Randomized Controlled Multicenter 3-Month Study [O] . Pasquale Aragona, Jose M Benítez-del-Castillo, Minas T Coroneo, 2020

机译：无羧甲基纤维素和干眼症透明质酸的防腐剂人造撕裂的安全性和有效性：随机控制多中心3个月的研究
7. Efficacy and safety of two new formulations of artificial tears in subjects with dry eye disease: a 3-month, multicenter, active-controlled, randomized trial [O] . Peter Simmons, Haixia Liu, Cindy Carlisle-Wilcox, 2015

机译：两种新的人工泪液在干眼症疾病中的疗效和安全性：3个月，多中心，主动控制，随机试验

Efficacy and safety of two new formulations of artificial tears in subjects with dry eye disease: a 3-month multicenter active-controlled randomized trial

摘要

著录项

相似文献

相关主题

期刊订阅